ctDNA Study
ASO Keyword Dashboard
Tracking 16 keywords for ctDNA Study in Google Play
ctDNA Study tracks 16 keywords (no keywords rank yet; 16 need traction). Key metrics: opportunity 72.0, difficulty 37.9.
This study will measure ctDNA from older patients with breast cancer.
Tracked keywords
16
0 ranked • 16 not ranking yet
Top 10 coverage
—
Best rank — • Latest leader —
Avg opportunity
72.0
Top keyword: patients
Avg difficulty
37.9
Lower scores indicate easier wins
Opportunity leaders
- 63.5
patients
Opportunity: 74.0 • Difficulty: 39.1 • Rank —
Competitors: 183
- 62.1
ongoing
Opportunity: 74.0 • Difficulty: 44.6 • Rank —
Competitors: 244
- 65.8
measure
Opportunity: 74.0 • Difficulty: 42.5 • Rank —
Competitors: 571
- 63.4
response
Opportunity: 74.0 • Difficulty: 39.4 • Rank —
Competitors: 289
- 64.8
treatment
Opportunity: 74.0 • Difficulty: 40.0 • Rank —
Competitors: 290
Unranked opportunities
patients
Opportunity: 74.0 • Difficulty: 39.1 • Competitors: 183
ongoing
Opportunity: 74.0 • Difficulty: 44.6 • Competitors: 244
measure
Opportunity: 74.0 • Difficulty: 42.5 • Competitors: 571
response
Opportunity: 74.0 • Difficulty: 39.4 • Competitors: 289
treatment
Opportunity: 74.0 • Difficulty: 40.0 • Competitors: 290
High competition keywords
monitor
Total apps: 64,057 • Major competitors: 1,639
Latest rank: — • Difficulty: 47.4
study
Total apps: 53,695 • Major competitors: 1,147
Latest rank: — • Difficulty: 48.0
specifically
Total apps: 27,088 • Major competitors: 541
Latest rank: — • Difficulty: 43.6
measure
Total apps: 13,467 • Major competitors: 571
Latest rank: — • Difficulty: 42.5
treatment
Total apps: 11,722 • Major competitors: 290
Latest rank: — • Difficulty: 40.0
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| monitor | 69 | 100 | 47 | 77 64,057 competing apps Median installs: 519 Avg rating: 1.8 | — | — | 1,639 major competitor apps |
| patients | 74 | 100 | 39 | 63 9,687 competing apps Median installs: 670 Avg rating: 1.9 | — | — | 183 major competitor apps |
| specifically | 72 | 100 | 44 | 71 27,088 competing apps Median installs: 733 Avg rating: 1.8 | — | — | 541 major competitor apps |
| ongoing | 74 | 100 | 45 | 62 7,956 competing apps Median installs: 757 Avg rating: 1.8 | — | — | 244 major competitor apps |
| measure | 74 | 100 | 42 | 66 13,467 competing apps Median installs: 1,235 Avg rating: 1.9 | — | — | 571 major competitor apps |
| response | 74 | 100 | 39 | 63 9,614 competing apps Median installs: 979 Avg rating: 1.9 | — | — | 289 major competitor apps |
| study | 70 | 100 | 48 | 75 53,695 competing apps Median installs: 1,121 Avg rating: 1.8 | — | — | 1,147 major competitor apps |
| cancer | 71 | 100 | 31 | 50 1,384 competing apps Median installs: 882 Avg rating: 1.9 | — | — | 36 major competitor apps |
| treatment | 74 | 100 | 40 | 65 11,722 competing apps Median installs: 879 Avg rating: 1.9 | — | — | 290 major competitor apps |
| primary | 74 | 100 | 43 | 64 10,336 competing apps Median installs: 1,222 Avg rating: 1.9 | — | — | 277 major competitor apps |
| prospective | 72 | 100 | 33 | 54 2,365 competing apps Median installs: 2,856 Avg rating: 2.0 | — | — | 38 major competitor apps |
| older | 74 | 100 | 43 | 60 6,219 competing apps Median installs: 3,452 Avg rating: 2.1 | — | — | 371 major competitor apps |
| breast | 70 | 100 | 30 | 46 760 competing apps Median installs: 1,441 Avg rating: 1.9 | — | — | 31 major competitor apps |
| therapy | 73 | 100 | 37 | 59 5,105 competing apps Median installs: 809 Avg rating: 2.0 | — | — | 91 major competitor apps |
| pills | 69 | 100 | 26 | 40 334 competing apps Median installs: 3,514 Avg rating: 2.4 | — | — | 20 major competitor apps |
| breast cancer | 68 | 100 | 21 | 34 126 competing apps Median installs: 552 Avg rating: 2.0 | — | — | 2 major competitor apps |
App Description
This study will measure ctDNA from older patients with breast cancer.